These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 10472707)

  • 1. [Generic drugs and right of substitution. Relating to Article 29 of the 1999 *social Security Financing Act].
    Meunier J; Thuillier A
    Ann Pharm Fr; 1999 Jul; 57(4):340-8; discussion 348-9. PubMed ID: 10472707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Generic medicines].
    Peláez de Loño J
    Rev Enferm; 1999 Dec; 22(12):836-43. PubMed ID: 10797771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Generic drugs and the rights of substitution].
    Vallée JP
    Presse Med; 1999 Mar; 28(10):535-8. PubMed ID: 10209545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of the Minimum Pricing Policy and introduction of brand (generic) substitution into the Pharmaceutical Benefits Scheme in Australia.
    McManus P; Birkett DJ; Dudley J; Stevens A
    Pharmacoepidemiol Drug Saf; 2001; 10(4):295-300. PubMed ID: 11760489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of generic substitution on price competition in Finland.
    Aalto-Setälä V
    Eur J Health Econ; 2008 May; 9(2):185-91. PubMed ID: 17508226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A legislative history of the Social Security Protection Act of 2004.
    Hansen E
    Soc Secur Bull; 2008; 68(4):41-52. PubMed ID: 19402460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Generic drug substitution].
    Tamir O; Halkin H; Shemer J
    Harefuah; 2006 Sep; 145(9):691-5, 701. PubMed ID: 17078434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generic drug utilisation on the General Medical Services (GMS) scheme in 2001.
    Tilson L; McGowan B; Ryan M; Barry M
    Ir Med J; 2003 Jun; 96(6):176-9. PubMed ID: 12926759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Social security: a program and policy history.
    Martin PP; Weaver DA
    Soc Secur Bull; 2005; 66(1):1-15. PubMed ID: 16295313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A political economy perspective: why pharmacists may be reluctant to dispense generic medications.
    Pelton LE; Strutton D; Smith MC
    J Hosp Mark; 1994; 9(1):137. PubMed ID: 10142135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Main roads in the legal project for financing Social Security 2010].
    Benaderette S
    Soins; 2009 Dec; (741):5. PubMed ID: 20067035
    [No Abstract]   [Full Text] [Related]  

  • 12. Are private physicians more likely to veto generic substitution of prescribed pharmaceuticals?
    Granlund D
    Soc Sci Med; 2009 Dec; 69(11):1643-50. PubMed ID: 19815322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring generic drug use behavior: the role of prescribers and pharmacists in the opportunity for generic drug use and generic substitution.
    Mott DA; Cline RR
    Med Care; 2002 Aug; 40(8):662-74. PubMed ID: 12187180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Generic drugs].
    Lemye R
    Rev Med Brux; 2000 Sep; 21(4):A273-5. PubMed ID: 11068479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Generic prescription by the physician is better than generic substitution by the pharmacy].
    Jakobsson S; Dahlqvist R; Håkansson J; Widäng K
    Lakartidningen; 2002 Mar; 99(10):1098-9. PubMed ID: 12024789
    [No Abstract]   [Full Text] [Related]  

  • 16. What are the obstacles to generic substitution? An assessment of the behaviour of prescribers, patients and pharmacies during the first year of generic substitution in Sweden.
    Andersson K; Sonesson C; Petzold M; Carlsten A; Lönnroth K
    Pharmacoepidemiol Drug Saf; 2005 May; 14(5):341-8. PubMed ID: 15624198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Customers' and physicians' opinions of and experiences with generic substitution during the first year in Finland.
    Heikkilä R; Mäntyselkä P; Hartikainen-Herranen K; Ahonen R
    Health Policy; 2007 Aug; 82(3):366-74. PubMed ID: 17141355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of generic drug supply in France].
    Taboulet F; Haramburu F; Latry P
    Rev Epidemiol Sante Publique; 2003 Sep; 51(4):415-25. PubMed ID: 13679734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Social protection. Main social risks managed by social security, mechanisms of financing of health expenditures].
    Riou F
    Rev Prat; 1994 Apr; 44(7):983-8. PubMed ID: 7939313
    [No Abstract]   [Full Text] [Related]  

  • 20. [Generic drugs and legal incentives: which impact?].
    Livio F; Buclin T; Pannatier A; Biollaz J
    Rev Med Suisse; 2006 Apr; 2(61):966-9. PubMed ID: 16686328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.